PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,819 | +11.0% | 3,065 | +13.1% | 0.00% | – |
| Q2 2023 | $16,958 | -21.5% | 2,709 | -40.2% | 0.00% | – |
| Q1 2023 | $21,608 | +218.8% | 4,530 | +481.5% | 0.00% | – |
| Q4 2022 | $6,777 | -99.9% | 779 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $9,200,000 | -16.5% | 773,096 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,016,000 | +18.6% | 773,051 | +73.3% | 0.00% | 0.0% |
| Q1 2022 | $9,288,000 | -20.0% | 446,119 | -11.3% | 0.00% | 0.0% |
| Q4 2021 | $11,612,000 | -40.5% | 502,700 | -23.2% | 0.00% | -50.0% |
| Q3 2021 | $19,501,000 | +7.6% | 654,400 | +23.3% | 0.00% | +100.0% |
| Q2 2021 | $18,129,000 | +30.8% | 530,714 | +25.9% | 0.00% | 0.0% |
| Q1 2021 | $13,860,000 | -46.6% | 421,400 | -0.2% | 0.00% | -50.0% |
| Q4 2020 | $25,970,000 | +77.9% | 422,200 | +2.7% | 0.00% | +100.0% |
| Q3 2020 | $14,598,000 | – | 411,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |